cyclophosphamide,fludarabine,emavusertib,alvelestat
curis,mereo biopharma,galapagos,Novartis
['fludarabine', 'lymphoma', 'atalanta-1', 'dlbcl', 'cyclophosphamide', 'nhl', 'take,aim,lymphoma', 'marginal zone lymphoma', 'atalanta-i', 'follicular', 'mantle,(-dismantle)', 'hodgkin', '$glpg', 'novartis', 'innovative,cellular,thera', 'roche,(-broche),(-rocheter),(-rochester)', 'gilead', 'adicet', 'bms', 'miltenyi', 'galapagos', 'takeda', 'celgene']
$glpg &amp; cellpoint presented encouraging initial data at #ash2022 for glpg5101, a cd19 car-t candidate manufactured at point-of-care 